Identification of two distinct types of four-transmembrane domain proteins, occludin and claudins: towards new physiology in paracellular pathway
Tsukita, S.; Furuse, M.
Seikagaku. Journal of Japanese Biochemical Society 72(3): 155-162
2000
ISSN/ISBN: 0037-1017 PMID: 10793575 Document Number: 522987
Document emailed within 1 workday
Related Documents
Jeansonne, B.; Lu, Q.; Goodenough, D.A.; Chen, Y.H. 2003: Claudin-8 interacts with multi-PDZ domain protein 1 (MUPP1) and reduces paracellular conductance in epithelial cells Cellular and Molecular Biology 49(1): 13-21Kennedy, D.; Wood, S.A.; Ramsdale, T.; Tam, P.P.; Steiner, K.A.; Mattick, J.S. 1996: Identification of a mouse orthologue of the human ras-GAP-SH3-domain binding protein and structural confirmation that these proteins contain an RNA recognition motif Biomedical Peptides Proteins and Nucleic Acids: Structure Synthesis and Biological Activity 2(3): 93-99
Cao, H.; Bangalore, L.; Bormann, B.J.; Stern, D.F. 1992: A subdomain in the transmembrane domain is necessary for p185neu* activation EMBO Journal 11(3): 923-932
Yasui, K.; Yamazaki, M.; Miyabayashi, M.; Tsuno, T.; Komiyama, A. 1994: Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. Distinct from the pathway for superoxide anion production Journal of Immunology 152(12): 5922-5929
Benderli Cihan, Y. 2018: Role of mTOR signaling pathway proteins and proteins influencing mTOR pathway in resistance to radiotherapy in prostate cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 23(6): 1931-1932
Johnson, B.D.; Hockerman, G.H.; Scheuer, T.; Catterall, W.A. 1996: Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines Molecular Pharmacology 50(5): 1388-1400
Makhovskaia, O.V.; Kozlov, S.; Botos, I.; Stepnov, A.A.; Andrianova, A.G.; Gushchina, A.E.; Vlodaver, A.; Mel'nikov, E.E.; Rotanova, T.V. 2007: Forms of LonB protease from Archaeoglobus fulgidus devoid of the transmembrane domain: the contribution of the quaternary structure to the regulation of enzyme proteolytic activity Bioorganicheskaia Khimiia 33(6): 657-660
Ishizaka, Y.; Ochiai, M.; Tahira, T.; Sugimura, T.; Nagao, M. 1989: Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing Oncogene 4(6): 789-794
Aguado, M.T.; Perrin, L.H.; Ramirez, R.; Miescher, P.A.; Lambert, P.H. 1980: Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins Clinical and Experimental Immunology 42(3): 495-505
Neer, E.J. 1986: Guanine nucleotide-binding proteins involved in transmembrane signaling Symposium on Fundamental Cancer Research 39: 123-136
Tang, B.L.; Low, S.H.; Wong, S.H.; Hong, W. 1995: Cell type differences in Golgi retention signals for transmembrane proteins European Journal of Cell Biology 66(4): 365-374
Takeda, S.; Kida, H.; Yokoyama, H.; Tomosugi, N.; Kobayashi, K. 1992: Two distinct types of crescentic glomerulonephritis Clinical Nephrology 37(6): 285-293
Sungkapong, T.; Culleton, R.; Yahata, K.; Tachibana, M.; Ruengveerayuth, R.; Udomsangpetch, R.; Torii, M.; Tsuboi, T.; Sattabongkot, J.; Kaneko, O.; Chotivanich, K. 2011: Humoral immune responses to Plasmodium vivax subtelomeric transmembrane proteins in Thailand Southeast Asian Journal of Tropical Medicine and Public Health 42(6): 1313-1321
Urano, T.; Emkey, R.; Feig, L.A. 1996: Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation EMBO Journal 15(4): 810-816
Mattson, C.; Wikström, K.; Sterky, C.; Pohl, G. 1991: Synergism between tissue-type plasminogen activator and a genetically engineered variant lacking the finger domain, the growth factor domain and the first kringle domain Thrombosis and Haemostasis 65(3): 286-290
Masliah, J.; Berguerand, M.; Bereziat, G. 1996: Coupling of seven transmembrane domains receptors cytosolic PLA2: role of G proteins and protein kinases Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 190(4): 417-423
De Seny, D.; Ribbens, C.; Cobraiville, G.; Meuwis, M.A.; Marée, R.; Geurts, P.; Wehenkel, L.; Louis, E.; Merville, M.P.; Fillet, M.; Malaise, M.G. 2009: Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest Revue Medicale de Liege 64(Special Issue): 29-35
Gaffney, E.V.; Ramos, L.; Fogh, J. 1970: Two distinct types of SV40-transformed human amnion cells Cancer Research 30(3): 871-879
Yan, Y.C. 1986: Sero-types in the hemorrhagic fever renal syndrome: I. An identification of sero-types of HFRS by hemagglutination inhibition assay Zhonghua Liu Xing Bing Xue Za Zhi 7(3): 135-137
Holst, J.; Lindblad, B.; Matthíasson, S.E.; Stjernquist, U.; Ezban, M.; Ostergaard, P.B.; Hedner, U. 1996: Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin Thrombosis and Haemostasis 75(4): 585-589